CoChat

Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future

Open access
Faison, Warachal E., Schultz, Susan K., Aerssens, Jeroen, Alvidrez, Jennifer, Anand, Ravi, Farrer, Lindsay A., Jarvik, Lissy, Manly, Jennifer, McRae, Thomas, Murphy, Greer M., Olin, Jason T., Regier, Darrel, Sano, Mary, Mintzer, Jacobo E. · 2007 · International Psychogeriatrics
Cited by 76

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Despite numerous clinical trials, it is unknown whether ethnicity affects treatment response to cognitive enhancers in Alzheimer's disease (AD). There is convincing evidence of ethnic and genetic variability in drug metabolism. This article reviews the available data on ethnicity in clinical trials for AD to answer two questions: (1) what are the challenges to diagnose and treat AD across different ethnic groups, and (2) are there differences in response to pharmacologic interventions for AD across these different ethnic groups? METHOD: Available data from Alzheimer's Disease Cooperative Study (ADCS) randomized controlled clinical trials and from randomized controlled industry-sponsored trials for four cognitive enhancers (donepezil, galantamine, rivastigmine and sabeluzole) were pooled to assess the numbers of non-Caucasian participants. RESULTS: The participation of ethnic minority subjects in clinical trials for AD was dependent on the funding source, although Caucasian participants were over-represented and non-Caucasian participants were under-represented in the clinical trials. Because of the low participation rate of ethnic minorities, there were insufficient data to assess any differences in treatment outcome among different ethnic groups. Strategies to improve diversity in clinical trials are discussed. CONCLUSION: Greater participation of ethnically diverse participants in clinical trials for AD would generate additional information on possible differences in metabolism, treatment response, adverse events to therapeutic agents, and could foster the investigation of genetic variability among ethnic groups.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s104161020700511x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 76

Metadata

Authors
Faison, W. E., Schultz, S. K., Aerssens, J., Alvidrez, J., Anand, R., Farrer, L. A., Jarvik, L., Manly, J., McRae, T., Murphy, G. M., Olin, J. T., Regier, D., Sano, M., & Mintzer, J. E.
Venue
International Psychogeriatrics
Publisher
Elsevier BV
Published
2007-06
Volume
19
Issue
3
Pages
539-558
ISSN
1041-6102 (ISSN-L)
OpenAlex
W2128641262
Cited by
76
References
3
FWCI
2.18
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future. https://app.cochat.ai/papers/10.1017/s104161020700511x
The paper
Faison, W. E., Schultz, S. K., Aerssens, J., Alvidrez, J., Anand, R., Farrer, L. A., Jarvik, L., Manly, J., McRae, T., Murphy, G. M., Olin, J. T., Regier, D., Sano, M., & Mintzer, J. E. (2007). Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future. International Psychogeriatrics. https://doi.org/10.1017/s104161020700511x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.